Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors

Virology

Volumn 410, Issue 1, 2011, Pages 192-200

  de Vrij, Jeroen ^a   van den Hengel, Sanne K ^a   Uil, Taco G ^a   Koppers Lalic, Danijela ^a   Dautzenberg, Iris J C ^a   Stassen, Oscar M J A ^a   Bárcena, Montserrat ^a   Yamamoto, Masato ^b   de Ridder, Corrina M A ^c   Kraaij, Robert ^c   Kwappenberg, Kitty M ^a   Schilham, Marco W ^a   Hoeben, Rob C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus; Coxsackie virus and adenovirus receptor; Gene therapy; Protein IX

Indexed keywords

ADENOVIRUS VECTOR; ALPHAVBETA5 INTEGRIN; BLOOD CLOTTING FACTOR 10; CAPSID PROTEIN; CAPSID PROTEIN IX; CD69 ANTIGEN; CD86 ANTIGEN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; GAMMA INTERFERON; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ADENOVIRUS 5; AGGREGATION; ANTIGEN EXPRESSION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL LINE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; INTERNALIZATION; LIVER; NATURAL KILLER CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL PHENOMENA; PRIORITY JOURNAL; PROTEIN BINDING; REPORTER GENE; TISSUE DISTRIBUTION; TRANSGENE; VIRUS PARTICLE;

ADENOVIRUSES, HUMAN; ANIMALS; CAPSID PROTEINS; CELL LINE, TUMOR; GENE DELETION; GENE TRANSFER TECHNIQUES; HUMANS; INTEGRINS; LIVER; MICE; RECEPTORS, VIRUS; VIRUS REPLICATION;

ADENOVIRIDAE; COXSACKIEVIRUS; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; MIRIDAE;

EID: 78650739878     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.040     Document Type: Article

References (43)

1. Atencio I.A., Grace M., Bordens R., Fritz M., Horowitz J.A., Hutchins B., Indelicato S., Jacobs S., Kolz K., Maneval D., Musco M.L., Shinoda J., Venook A., Wen S., Warren R. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Ther. 2006, 13:169-181.
2. Au T., Thorne S., Korn W.M., Sze D., Kirn D., Reid T.R. Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver. Cancer Gene Ther. 2007, 14:139-150.
3. Bangari D.S., Shukla S., Mittal S.K. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochem. Biophys. Res. Commun. 2005, 327:960-966.
4. Bayer W., Tenbusch M., Lietz R., Johrden L., Schimmer S., Uberla K., Dittmer U., Wildner O. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection. J. Virol. 2010, 84:1967-1976.
5. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (New York, N.Y.) 1997, 275:1320-1323.
6. Boyer J., Sofer-Podesta C., Ang J., Hackett N., Chiuchiolo M., Senina S., Perlin D., Crystal R. Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into the adenovirus capsid. Hum. Gene Ther. 2010, 21:891-901.
7. Cambiaggi C., Scupoli M.T., Cestari T., Gerosa F., Carra G., Tridente G., Accolla R.S. Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12. Immunogenetics 1992, 36:117-120.
8. Caravokyri C., Leppard K.N. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J. Virol. 1995, 69:6627-6633.
9. Carlotti F., Bazuine M., Kekarainen T., Seppen J., Pognonec P., Maassen J.A., Hoeben R.C. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol. Ther. 2004, 9:209-217.
10. Corjon S., Wortmann A., Engler T., van Rooijen N., Kochanek S., Kreppel F. Targeting of adenovirus vectors to the LRP receptor family with the high-affinity ligand RAP via combined genetic and chemical modification of the pIX capsomere. Mol. Ther. 2008, 16:1813-1824.
11. de Haan C.A., Li Z., te Lintelo E., Bosch B.J., Haijema B.J., Rottier P.J. Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J. Virol. 2005, 79:14451-14456.
12. de Vrij J., Uil T.G., van den Hengel S.K., Cramer S.J., Koppers-Lalic D., Verweij M.C., Wiertz E.J.H.J., Vellinga J., Willemsen R.A., Hoeben R.C. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX. Gene Ther. 2008, 15:978-989.
13. Di Paolo N.C., Shayakhmetov D.M. Adenovirus de-targeting from the liver. Curr. Opin. Mol. Ther. 2009, 11:523-531.
14. Drouin M., Cayer M.P., Jung D. Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor. Virology 2010, 401:305-313.
15. Fabry C.M., Rosa-Calatrava M., Conway J.F., Zubieta C., Cusack S., Ruigrok R.W., Schoehn G. A quasi-atomic model of human adenovirus type 5 capsid. EMBO J. 2005, 24:1645-1654.
16. Fabry C.M.S., Rosa-Calatrava M., Moriscot C., Ruigrok R.W.H., Boulanger P., Schoehn G. The C-terminal domains of adenovirus serotype 5 protein IX assemble into an antiparallel structure on the facets of the capsid. J. Virol. 2009, 83:1135-1139.
17. Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., Van Ormondt H., Hoeben R.C., Van Der Eb A.J. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 1996, 7:215-222.
18. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 1998, 95:2509-2514.
19. He X.S., Draghi M., Mahmood K., Holmes T.H., Kemble G.W., Dekker C.L., Arvin A.M., Parham P., Greenberg H.B. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J. Clin. Invest. 2004, 114:1812-1819.
20. Heemskerk B., Veltrop-Duits L.A., van Vreeswijk T., ten Dam M.M., Heidt S., Toes R.E., van Tol M.J., Schilham M.W. Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J. Virol. 2003, 77:6562-6566.
21. Hong J.S., Engler J.A. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virology 1991, 185:758-767.
22. Kalyuzhniy O., Di Paolo N.C., Silvestry M., Hofherr S.E., Barry M.A., Stewart P.L., Shayakhmetov D.M. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc. Natl Acad. Sci. USA 2008, 105:5483-5488.
23. Klein B., Pastink A., Odijk H., Westerveld A., van der Eb A.J. Transformation and immortalization of diploid xeroderma pigmentosum fibroblasts. Exp. Cell Res. 1990, 191:256-262.
24. McNees A.L., Mahr J.A., Ornelles D., Gooding L.R. Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines. J. Virol. 2004, 78:6955-6966.
25. Murakami P., McCaman M.T. Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent Dye. Anal. Biochem. 1999, 274:283-288.
26. Muruve D.A. The innate immune response to adenovirus vectors. Hum. Gene Ther. 2004, 15:1157-1166.
27. Nemerow G.R., Stewart P.L. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. Rev. 1999, 63:725-734.
28. Ono H.A., Le L.P., Davydova J.G., Gavrikova T., Yamamoto M. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region. Cancer Res. 2005, 65:10154-10158.
29. Patterson S., Russell W.C. Ultrastructural and immunofluorescence studies of early events in adenovirus-HeLa cell interactions. J. Gen. Virol. 1983, 64:1091-1099.
30. Reiser H., Stadecker M.J. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J. Med. 1996, 335:1369-1377.
31. Saban S.D., Silvestry M., Nemerow G.R., Stewart P.L. Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J. Virol. 2006, 80:12049-12059.
32. Sittler A., Gallinaro H., Jacob M. The secondary structure of the adenovirus-2L4 polyadenylation domain: evidence for a hairpin structure exposing the AAUAAA signal in its loop. J. Mol. Biol. 1995, 248:525-540.
33. Tang Y., Wu H., Ugai H., Matthews Q.L., Curiel D.T. Derivation of a triple mosaic adenovirus for cancer gene therapy. PLoS ONE 2009, 4:e8526.
34. Trinchieri G., Matsumoto-Kobayashi M., Clark S.C., Seehra J., London L., Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. J. Exp. Med. 1984, 160:1147-1169.
35. Uil T.G., de Vrij J., Vellinga J., Rabelink M.J.W.E., Cramer S.J., Chan O.Y.A., Pugnali M., Magnusson M., Lindholm L., Boulanger P., Hoeben R.C. A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers. J. Gene Med. 2009, 11:990-1004.
36. Vellinga J., de Vrij J., Myhre S., Uil T., Martineau P., Lindholm L., Hoeben R.C. Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid. Gene Ther. 2007, 14:664-670.
37. Vellinga J., Rabelink M.J.W.E., Cramer S.J., van den Wollenberg D.J.M., Van der Meulen H., Leppard K.N., Fallaux F.J., Hoeben R.C. Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX. J. Virol. 2004, 78:3470-3479.
38. Vellinga J., Uil T.G., de Vrij J., Rabelink M.J.W.E., Lindholm L., Hoeben R.C. A system for efficient generation of adenovirus protein IX-producing helper cell lines. J. Gene Med. 2006, 8:147-154.
39. Vellinga J., van den Wollenberg D.J.M., van der Heijdt S., Rabelink M.J.W.E., Hoeben R.C. The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability. J. Virol. 2005, 79:3206-3210.
40. Vellinga J., Van der Heijdt S., Hoeben R.C. The adenovirus capsid: major progress in minor proteins. J. Gen. Virol. 2005, 86:1581-1588.
41. Waddington S.N., McVey J.H., Bhella D., Parker A.L., Barker K., Atoda H., Pink R., Buckley S.M.K., Greig J.A., Denby L., Custers J., Morita T., Francischetti I.M.B., Monteiro R.Q., Barouch D.H., van Rooijen N., Napoli C., Havenga M.J.E., Nicklin S.A., Baker A.H. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008, 132:397-409.
42. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73:309-319.
43. Xu Z., Tian J., Smith J.S., Byrnes A.P. Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J. Virol. 2008, 82:11705-11713.